• Publications
  • Influence
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
Nonrandomised studies, including case-control and cohort studies, can be challenging to implement and conduct. Assessment of the quality of such studies is essential for a proper understanding ofExpand
Real world research.
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews
A measurement tool for the 'assessment of multiple systematic reviews' (AMSTAR) was developed that consists of 11 items and has good face and content validity for measuring the methodological quality of systematic reviews. Expand
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Risk of Bias In Non-randomised Studies - of Interventions is developed, a new tool for evaluating risk of bias in estimates of the comparative effectiveness of interventions from studies that did not use randomisation to allocate units or clusters of individuals to comparison groups. Expand
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.
Twenty-five carefully worded recommendations have been generated based on a critical appraisal of existing guidelines, a systematic review of research evidence and the consensus opinions of an international, multidisciplinary group of experts for the management of hip and knee osteoarthritis. Expand
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
To update the American College of Rheumatology (ACR) 2000 recommendations for hip and knee osteoarthritis (OA) and develop new recommendations for hand OA.
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
This paper reports on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. Expand
A simplified disease activity index for rheumatoid arthritis for use in clinical practice.
The SDAI is a valid and sensitive assessment of disease activity and treatment response that is comparable with the DAS 28 and ACR response criteria; it is easy to calculate and therefore a viable tool for day-to-day clinical assessment of RA treatment. Expand
CARE guidelines for case reports: explanation and elaboration document.
This explanation and elaboration document is designed to increase the use and dissemination of the CARE Checklist in writing and publishing case reports and is resources for improving the completeness and transparency of case reports. Expand
Developing core outcome sets for clinical trials: issues to consider
The need for general guidance on the development of core outcome sets, which should be measured and reported, as a minimum, in all trials for a specific clinical area, is identified. Expand